Targeted Photodynamic Therapy for Improved Lung Cancer Treatment

  • Crous A
  • Abrahamse H
N/ACitations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Cancer develops from the outgrowth of a clonal population of cells with a genetic pathology to evade cell death and exponential proliferation. It has become a global burden with increasing mortality rates. Lung cancer is a major contributor to cancer fatalities. Conventional therapies have shown advances in treating lung cancer, but the successful eradica-tion of cancer lies in targeting both cancer and cancer stem cells. Cancer stem cells (CSCs) are a ration of cells found within the tumour bulk, capable of cancer initiation, therapy resistance, metastasis and cancer relapse. Photodynamic therapy (PDT) has proven effective in treating lung cancer. PDT exerts selective cell death mechanisms toward cancerous cells. With the use of a photosensitizer (PS) which becomes excited upon irradiation with laser light at a specific wavelength, the PS forms reactive oxygen species (ROS) in turn killing neoplastic cells. Leading therapeutic sequel can be obtained by transcending PDT though combination therapies such as immunotherapy and nanotechnology which will enable PDT to target lung CSCs preventing lung cancer recurrence.

Cite

CITATION STYLE

APA

Crous, A., & Abrahamse, H. (2018). Targeted Photodynamic Therapy for Improved Lung Cancer Treatment. In Lung Cancer - Strategies for Diagnosis and Treatment. InTech. https://doi.org/10.5772/intechopen.78699

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free